publications

 

As we advance our mission to develop breakthrough therapies with the goal of fundamentally changing the way we treat, prevent, and control progressive and infectious respiratory diseases, we regularly share the progress of our research.

To learn more about our science and research findings, download the PDFs below:


ATS 713 — Inhaled Calcium Salts Reduce Acute Airway Inflammation Associated with Tobacco Smoke Exposure / PDF

ATS C60 — Inhaled Cationic Salts Inhibit Infection of Multiple Viral Pathogens and Prevent Influenza Infection in Vivo / PDF

ATS C22 — Efficacy of Fluticasone and Salmeterol in a Novel Inhaled Dry Powder Delivery Platform / PDF

ISAM 2011 Conference abstract — Deposition of Aerosolized Liquid Formulation in Ferrets by 3D CT / Spect Imaging / PDF

ISAM 2011 Conference abstract — A Novel Inhaled Dry Powder Delivery Platform; Efficacy of Fluticasone and Salmeterol During Allergic Asthm / PDF

 
 
 
© 2011 Pulmatrix, Inc. All Rights Reservedhome   about pulmatrix   science   pipeline   applications   publications   news   careers   contact   site design